Aura Biosciences, Inc.

AURA · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$47,553$107,367$38,226$31,693
Short-Term Investments$114,313$69,944$89,765$119,401
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$8,254$6,647$6,526$9,529
Total Curr. Assets$170,120$183,958$134,517$160,623
Property Plant & Equip (Net)$18,859$19,486$20,116$20,594
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$768$0$0
Tax Assets$0$0$0$0
Other NC Assets$1,045$185$768$1,286
Total NC Assets$19,904$20,439$20,884$21,880
Other Assets$0$0$0$0
Total Assets$190,024$204,397$155,401$182,503
Liabilities
Payables$1,888$1,286$2,006$2,304
Short-Term Debt$3,220$3,196$3,172$3,149
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$13,715$10,370$6,985$9,460
Total Curr. Liab.$18,823$14,852$12,163$14,913
LT Debt$14,534$14,916$15,272$15,620
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$14,534$14,916$15,272$15,620
Other Liabilities$0$0$0$0
Cap. Leases$17,754$18,112$18,444$18,769
Total Liabilities$33,357$29,768$27,435$30,533
Equity
Pref Stock$0$0$0$0
Common Stock$0$0$0$0
Retained Earnings-$454,859-$428,729-$401,710-$374,227
AOCI$69$25$105$263
Other Equity$611,457$603,333$529,571$525,934
Total Equity$156,667$174,629$127,966$151,970
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$190,024$204,397$155,401$182,503
Net Debt-$29,799-$89,255-$19,782-$12,924